Dr. Martens (LON:DOCS) Trading Down 10.9% – Time to Sell?

Shares of Dr. Martens plc (LON:DOCS) dropped 10.9% during trading on Thursday . The stock traded as low as GBX 72.30 and last traded at GBX 72.70. Approximately 3,233,615 shares changed hands during trading, an increase of 47% from the average daily volume of 2,197,348 shares. The stock had previously closed at GBX 81.60.

Analysts Set New Price Targets

Separately, Peel Hunt raised shares of Dr. Martens to a “buy” rating in a report on Monday, August 18th. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of GBX 6,000.

Dr. Martens Trading Down 10.9%

The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85. The firm’s fifty day simple moving average is GBX 90.64 and its 200-day simple moving average is GBX 80.35. The stock has a market cap of £702.52 million, a P/E ratio of 145.40, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11.

Dr. Martens (LON:DOCS) last issued its earnings results on Thursday, November 20th. The company reported GBX (0.90) earnings per share (EPS) for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. Equities research analysts expect that Dr. Martens plc will post 2.5809394 EPS for the current fiscal year.

Insider Activity

In other Dr. Martens news, insider Giles Wilson acquired 105,838 shares of the company’s stock in a transaction on Monday, September 1st. The stock was acquired at an average price of GBX 91 per share, for a total transaction of £96,312.58. Also, insider Ije Nwokori sold 298,675 shares of the stock in a transaction that occurred on Wednesday, October 15th. The stock was sold at an average price of GBX 90, for a total value of £268,807.50. In the last three months, insiders have bought 136,960 shares of company stock valued at $12,460,163 and have sold 434,460 shares valued at $39,131,400. 2.80% of the stock is currently owned by insiders.

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.